Storia in 11 fonti

Trump's 200% tariff plan may be a bitter pill for US consumers; Dr Reddy's warns of costlier medicines

The US is putting generic medicines on the tariff map, with duties set to rise to as much as 200% in the coming years to boost local manufacturing. But will the cure soothe the pain for American consumers—or inflame it further?

Raccontata da

timesofindia.indiatimes.com

economictimes.indiatimes.com

thehindubusinessline.com

theprint.in

asia.nikkei.com

scmp.com

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

timesofindia.indiatimes.comStai leggendo1 mese fa

Trump's 200% tariff plan may be a bitter pill for US consumers; Dr Reddy's warns of costlier medicines

originale

Timeline cronologica

mercoledì 22 luglio 2026·timesofindia.indiatimes.com
Trump announces 0% tariff on generic medicines for two years; 200% thereafter
US President Donald Trump on Tuesday announced a phased tariff regime on imported generic medicines, saying they will continue to enter the United States duty-free for two years…
mercoledì 22 luglio 2026·economictimes.indiatimes.com
Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%

Trump ⁠has been pressuring drugmakers through his most-favored-nation drug pricing policy to lower prices to what people pay in other high-income countries.

Trump's 200% tariff plan may be a bitter pill for US consumers; Dr Reddy's warns of costlier medicines

Confronto fonti

Trump's 200% tariff plan may be a bitter pill for US consumers; Dr Reddy's warns of costlier medicines

Timeline cronologica

Trump announces 0% tariff on generic medicines for two years; 200% thereafter

Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%

Indian pharma firms may yet survive Trump's 200% tariff bombshell

U.S. to see higher generic drug prices thanks to tariffs, CEO of leading India pharma firm warns

Trump threatens tariff on generic medicines: Should India be worried?

Trump plans 100% tariffs on imported generic drugs. Here's what experts say.

Trump’s proposed generic drug tariffs ‘not practical’, says Indian pharma; US consumers will pay the price

Trump announces 100% tariffs on imported generic pharmaceutical drugs

Trump Sets August 1 Start for Generic Drug Tariff Clock, Warns of 200% Duties: Companies Must 'Build Plan

0% for two years, 100% for one, 200 after: US' latest tariff move over generic medicines

0%, 100%, then 200%: How Trump's new generic drug tariff plan could hit India

Trump threatens tariff on generic medicines: Should India be worried?

Trump’s 100% Generic Drug Duty Threatens US Low-Cost Supply

0, 100, 200: How Trump's latest generic medicines tariffs could affect India

Trump’s proposed generic drug tariffs ‘not practical’, says Indian pharma; US consumers will pay the price

0% now, 100% in 2 years, 200% by 2029—US plan for generic pharma tariffs & what it means for India

Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% storm

Trump's 200% drug tariff plan: Is India's pharma industry about to face an economic storm?

Trump’s 100% generic drug duty threatens US low-cost supply

200% Trump tariff shock? India’s cheap pills may still beat US rivals

Indian pharma firms may yet survive Trump's 200% tariff bombshell

Explained: What Donald Trump's up to 200% pharma tariffs mean for Indian investors

Donald Trump’s 200% tariffs on pharma: Why India’s generic medicines could still remain competitive

Trump's generic drugs tariff threatens Indian pharma's top market

What would 200% US tariffs on generic drugs mean for China’s pharmaceutical industry?